Guidelines for the diagnosis and treatment of basal cell carcinoma: a GRADE approach for evidence evaluation and recommendations by the Italian Association of Medical Oncology.

GRADE basal cell carcinoma guidelines keratinocyte carcinoma skin cancer

Journal

ESMO open
ISSN: 2059-7029
Titre abrégé: ESMO Open
Pays: England
ID NLM: 101690685

Informations de publication

Date de publication:
23 Oct 2023
Historique:
received: 29 05 2023
accepted: 20 09 2023
medline: 26 10 2023
pubmed: 26 10 2023
entrez: 25 10 2023
Statut: aheadofprint

Résumé

Basal cell carcinoma (BCC) is the most common form of cancer, with a high impact on the public health burden and social costs. Despite the overall prognosis for patients with BCC being excellent, if lesions are allowed to progress, or in a small subset of cases harboring an intrinsically aggressive biological behavior, it can result in local spread and significant morbidity, and conventional treatments (surgery and radiotherapy) may be challenging. When a BCC is not amenable to either surgery or radiotherapy with a reasonable curative intent, or when metastatic spread occurs, systemic treatments with Hedgehog inhibitors are available. These guidelines were developed, applying the GRADE approach, on behalf of the Italian Association of Medical Oncologists (AIOM) to assist clinicians in treating patients with BCC. They contain recommendations with regard to the diagnosis, treatment and follow-up, from primitive tumors to those locally advanced or metastatic, addressing the aspects of BCC management considered as priorities by a panel of experts selected by AIOM and other national scientific societies. The use of these guidelines in everyday clinical practice should improve patient care.

Identifiants

DOI: 10.1016/j.esmoop.2023.102037 PMID: 37879235 PMC: PMC10598491
pubmed: 37879235
pii: S2059-7029(23)01278-4
doi: 10.1016/j.esmoop.2023.102037
pmc: PMC10598491
pii:
doi:

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

102037

Informations de copyright

Copyright © 2023 The Author(s). Published by Elsevier Ltd.. All rights reserved.

Références

Clin Cancer Res. 2019 Apr 15;25(8):2379-2391
pubmed: 30523023
J Am Acad Dermatol. 2000 Mar;42(3):389-413; quiz 414-6
pubmed: 10688709
Lancet Oncol. 2008 Dec;9(12):1149-56
pubmed: 19010733
Cochrane Database Syst Rev. 2016 Jul 25;7:CD011161
pubmed: 27455163
Int J Radiat Oncol Biol Phys. 2005 Nov 1;63(3):753-7
pubmed: 15927410
Eur J Cancer. 2016 Aug;63:41-52
pubmed: 27267144
Photodermatol Photoimmunol Photomed. 2015 Jan;31(1):44-53
pubmed: 25377432
Dermatol Surg. 2003 Jun;29(6):650-2
pubmed: 12786712
J Invest Dermatol. 2017 Mar;137(3):614-619
pubmed: 27932240
J Am Acad Dermatol. 1988 Jul;19(1 Pt 2):176-85
pubmed: 3165982
Br J Dermatol. 2021 Feb;184(2):208-218
pubmed: 32320481
Br J Dermatol. 2020 Jun;182(6):1369-1378
pubmed: 31545507
J Eur Acad Dermatol Venereol. 2020 Sep;34(9):1944-1956
pubmed: 31990414
JAMA Dermatol. 2016 Jul 1;152(7):816-24
pubmed: 27096888
Strahlenther Onkol. 2014 Mar;190(3):245-9
pubmed: 24424628
Crit Rev Oncol Hematol. 2016 Feb;98:235-41
pubmed: 26614022
Sci Rep. 2019 Mar 12;9(1):4285
pubmed: 30862897
BMJ. 2016 Mar 08;352:i1152
pubmed: 26957104
J Natl Compr Canc Netw. 2004 Jan;2(1):6-27
pubmed: 19777692
Lancet Oncol. 2013 Jun;14(7):647-54
pubmed: 23683751
Ophthalmology. 2004 Apr;111(4):631-6
pubmed: 15051193
J Eur Acad Dermatol Venereol. 2018 Mar;32(3):372-381
pubmed: 28846163
J Am Acad Dermatol. 2021 Apr;84(4):1162-1164
pubmed: 33358380
Arch Dermatol. 1991 Aug;127(8):1194-7
pubmed: 1863078
Cochrane Database Syst Rev. 2020 Nov 17;11:CD003412
pubmed: 33202063
J Invest Dermatol. 2016 Aug;136(8):1568-1574
pubmed: 27113429
J Dermatol Surg Oncol. 1991 Sep;17(9):720-6
pubmed: 1820764
Pediatrics. 2014 Jul;134(1):e4-12
pubmed: 24958589
Plast Reconstr Surg. 2010 Oct;126(4):1222-1231
pubmed: 20885244
J Am Acad Dermatol. 2021 Aug;85(2):388-395
pubmed: 33852922
J Am Acad Dermatol. 2015 Jul;73(1):166-8
pubmed: 26089054
Br J Dermatol. 2014 Apr;170(4):809-15
pubmed: 24283541
N Engl J Med. 2012 Jun 7;366(23):2171-9
pubmed: 22670903
Eur J Cancer. 1990 Jan;26(1):73-7
pubmed: 2138485
Aust N Z J Public Health. 2015 Oct;39(5):471-6
pubmed: 26437734
Ann Pharmacother. 1996 Jun;30(6):662-73
pubmed: 8792954
J Cosmet Dermatol. 2016 Dec;15(4):374-382
pubmed: 27363535
J Am Acad Dermatol. 2016 Jun;74(6):1093-106
pubmed: 26896294
J Am Acad Dermatol. 2015 Jun;72(6):1021-6.e8
pubmed: 25981002
Dermatol Surg. 2017 Jul;43(7):920-927
pubmed: 28291062
J Dermatol Surg Oncol. 1989 Apr;15(4):424-31
pubmed: 2925988
Lancet Oncol. 2014 Jan;15(1):96-105
pubmed: 24332516
Dermatol Surg. 2009 Jan;35(1):24-9
pubmed: 19018814
J Am Acad Dermatol. 2014 Feb;70(2):303-11
pubmed: 24268311
Int J Dermatol. 2016 Dec;55(12):1351-1356
pubmed: 27419915
Trials. 2010 Apr 21;11:42
pubmed: 20409337
Tumori. 2002 Jan-Feb;88(1):48-52
pubmed: 12004850
J Clin Oncol. 2014 Mar 10;32(8):745-51
pubmed: 24493717
Ann Intern Med. 2011 Feb 1;154(3):190-201
pubmed: 21282699
Br J Cancer. 1997;76(1):100-6
pubmed: 9218740
Lancet. 1999 Aug 28;354(9180):723-9
pubmed: 10475183
Lancet. 2004 Nov 13-19;364(9447):1766-72
pubmed: 15541449
Arch Dermatol. 2001 Sep;137(9):1162-8
pubmed: 11559211
J Am Acad Dermatol. 2005 Dec;53(6):993-1001
pubmed: 16310060
Eur J Cancer. 2014 Mar;50(4):774-83
pubmed: 24412051
BMJ. 2004 Sep 25;329(7468):705
pubmed: 15364703
J Am Acad Dermatol. 2012 Dec;67(6):1235-41
pubmed: 22818756
Br J Dermatol. 2014 Nov;171(5):1044-51
pubmed: 24891083
J Transl Med. 2017 May 31;15(1):122
pubmed: 28569161
Lancet Oncol. 2021 Jun;22(6):848-857
pubmed: 34000246
Eur J Cancer. 2014 Nov;50(17):3011-20
pubmed: 25262378
Lancet Oncol. 2017 Mar;18(3):404-412
pubmed: 28188086
J Cancer. 2012;3:257-61
pubmed: 22712026
Lancet Oncol. 2015 Jun;16(6):729-36
pubmed: 25981813
Br J Dermatol. 2012 Aug;167 Suppl 2:76-84
pubmed: 22881591
Dermatol Clin. 1998 Apr;16(2):313-20
pubmed: 9589204
Anticancer Res. 2015 Sep;35(9):4949-53
pubmed: 26254393
Photodermatol Photoimmunol Photomed. 2011 Apr;27(2):58-67
pubmed: 21392107
Future Oncol. 2015;11(4):703-12
pubmed: 25686123
J Eur Acad Dermatol Venereol. 2009 Sep;23(9):1044-9
pubmed: 19368616
Br J Oral Maxillofac Surg. 2004 Aug;42(4):311-4
pubmed: 15225948
BMJ. 2016 Jun 30;353:i2089
pubmed: 27365494
Ther Clin Risk Manag. 2008 Apr;4(2):541-8
pubmed: 18728828
J Am Acad Dermatol. 2005 Sep;53(3):452-7
pubmed: 16112352
Oncology (Williston Park). 2005 Aug;19(9):1165-71; discussion 1171-2, 1175
pubmed: 16255133
J Am Acad Dermatol. 1991 May;24(5 Pt 1):715-9
pubmed: 1869642
J Clin Oncol. 2006 Apr 20;24(12):1877-82
pubmed: 16622262
J Eur Acad Dermatol Venereol. 2012 Aug;26(8):942-52
pubmed: 22211959
Am J Epidemiol. 2005 Apr 15;161(8):748-54
pubmed: 15800267
J Clin Oncol. 2012 May 10;30(14):1588-93
pubmed: 22370316
N Engl J Med. 2009 Sep 17;361(12):1164-72
pubmed: 19726763
Eur J Surg Oncol. 2020 May;46(5):847-854
pubmed: 31862134
Br J Dermatol. 2014 Apr;170(4):802-8
pubmed: 24124911
Head Neck. 2009 May;31(5):604-10
pubmed: 19132719
J Am Acad Dermatol. 2018 Mar;78(3):560-578
pubmed: 29331386
Int J Radiat Oncol Biol Phys. 1991 Mar;20(3):423-8
pubmed: 1899855
Dermatol Surg. 2000 Aug;26(8):759-64
pubmed: 10940063
Skin Res Technol. 2016 May;22(2):230-7
pubmed: 26338448

Auteurs

P Queirolo (P)

Division of Melanoma, Sarcomas and Rare Tumors, European Institute of Oncology, Milan.

M Cinquini (M)

Istituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan.

G Argenziano (G)

Dermatology Unit, Department of Mental and Physical Health and Preventive Medicine, University of Campania Luigi Vanvitelli, Naples.

F Bassetto (F)

Clinic of Plastic Surgery, Department of Neuroscience, Padua University Hospital, Padua.

P Bossi (P)

Medical Oncology, Department of Medical and Surgical Specialties, Radiological Sciences and Public Health University of Brescia, ASST-Spedali Civili, Brescia.

A Boutros (A)

Department of Internal Medicine and Medical Specialties, School of Medicine, University of Genoa, Genoa.

C Clemente (C)

UO SMEL-2, Surgical Pathology, Department of Pathology and Laboratory Medicine, IRCCS-Policlinico San Donato, Milan.

V de Giorgi (V)

Dermatology Unit, Azienda USL Toscana Centro, Florence; Section of Dermatology, Department of Health Sciences, University of Florence, Florence.

M Del Vecchio (M)

Department of Medical Oncology, Fondazione IRCCS Istituto Nazionale dei Tumori, Milan.

R Patuzzo (R)

Fondazione IRCCS Istituto Nazionale Dei Tumori, Melanoma and Sarcoma Unit, Milan.

K Peris (K)

Dermatology, Department of Translational Medicine and Surgery, Università Cattolica del Sacro Cuore, Rome; Dermatology, Department of Medical and Surgical Sciences, Fondazione Policlinico Universitario A. Gemelli IRCCS, Rome.

P Quaglino (P)

Department of Medical Sciences, Clinic of Dermatology, University of Turin, Turin.

A Reali (A)

Radiation Oncology Department, Michele e Pietro Ferrero Hospital, Verduno.

I Zalaudek (I)

Dermatology Clinic, Maggiore Hospital, University of Trieste, Trieste.

F Spagnolo (F)

Oncologia Medica 2, IRCCS Ospedale Policlinico San Martino, Genoa; Department of Integrated Surgical and Diagnostic Sciences (DISC), University of Genoa, Genoa, Italy. Electronic address: francesco.spagnolo85@gmail.com.

Classifications MeSH